Bcl10 activates the NF-κB pathway through ubiquitination of NEMO

Nature

Volumn 427, Issue 6970, 2004, Pages 167-171

  Zhou, Honglin ^a   Wertz, Ingrid ^a,b   O'Rourke, Karen ^a   Ultsch, Mark ^a   Seshagir, Somasekar ^a   Eby, Michael ^a   Xiao, Wei ^c   Dixit, Vishva M ^a  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; PROTEINS; RNA;

MUTANTS;

GENES;

CASPASE; I KAPPA B KINASE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BCL 10; RNA; TRANSCRIPTION FACTOR; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG;

MEDICINE;

ARTICLE; B LYMPHOCYTE; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CASPASES; CELL LINE; GENE DELETION; HUMANS; I-KAPPA B KINASE; JURKAT CELLS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; NEOPLASM PROTEINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES;

EID: 0345826149     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02273     Document Type: Article

References (28)

1. Silverman, N. & Maniatis, T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15, 2321-2342 (2001).
2. Dixit, V. M. & Mak, T. W. NF-κB signaling: Many roads lead to Madrid. Cell 111, 615-619 (2002).
3. Ruland, J. et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104, 33-42 (2001).
4. Lucas, P. C. et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κB signaling pathway. J. Biol. Chem. 276, 19012-19019 (2001).
5. Rothwarf, D. M. & Karin, M. The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE 5, RE1 (1999).
6. Ben-Neriah, Y. Regulatory functions of ubiquitination in the immune system. Nature Immunol. 3, 20-26 (2002).
7. Hoffmann, A., Levchenko, A., Scott, M. L. & Baltimore, D. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298, 1241-1245 (2002).
8. Willis, T. G. et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96, 35-45 (1999).
9. Zhang, Q. et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nature Genet. 22, 63-68 (1999).
10. Thome, M. & Tschopp, J. TCR-induced NF-κB activation: a crucial role for Carmal. Bcl10 and MALT1. Trends Immunol. 24, 419-424 (2003).
11. Uren, A. G. et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6, 961-967 (2000).
12. Shi, C. S. & Kehrl, J. H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278, 15429-15434 (2003).
13. Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
14. Weissman, A. M. Themes and variations on ubiquitylation. Nature Rev. Mol. Cell Biol. 2, 169-178 (2001).
15. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
16. Hoege, C. et al. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135-141 (2002).
17. Makris, C., Roberts, J. L. & Karin, M. The carboxyl-terminal region of IκB kinase gamma (IKKγ) is required for full IKK activation. Mol. Cell. Biol. 22, 6573-6581 (2002).
18. Smahi, A. et al. Genomic rearrangement in NEMO impairs NF-B activation and is a cause of incontinentia pigment. Nature 405, 466-472 (2000).
19. Yamaoka, S. et al. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93, 1231-1240 (1998).
20. Harhaj, E. W. et al. Somatic mutagenesis studies of NF-κB signaling in human T cells: evidence for an essential role of IKKγ in NF-κB activation by T cell costimulatory signals and HTLV-I Tax protein. Oncogene 19, 1448-1456 (2000).
21. Ohi, M. D. et al. Structural insights into the U-box, a domain associated with multi-ubiquitination. Nature Struct. Biol. 10, 250-255 (2003).
22. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81-S96 (2002).
23. Kovalenko, A. et al. The tumour suppressor CYLD negatively regulates NF-B signalling by deubiquitination. Nature 424, 801-805 (2003).
24. Brummelkamp, T. et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801 (2003).
25. Trompouki, E. et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-B activation by TNFR family members. Nature 424, 793-796 (2003).
26. Harbury, P. B. et al. A switch between two, three- and four-stranded coiled coil in GCN4 leucine zipper mutants. Science 262, 1401-1407 (1993).
27. Li, M. et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653 (2002).
28. Moraes, T. F. et al. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2-hUbc13. Nature Struct. Biol. 8, 669-673 (2001).